Evidence map›Paper›PMID 21439057›Full record

ArticleBMC public health2011

Cardiovascular disease prevention in rural Nigeria in the context of a community based health insurance scheme: QUality Improvement Cardiovascular care Kwara-I (QUICK-I).

Marleen Hendriks, Lizzy Brewster, Ferdinand Wit, Oladimeji Akeem Bolarinwa, Aina Olufemi Odusola, William Redekop, Navin Bindraban, Albert Vollaard, Shade Alli, Peju Adenusi and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 3 countries.

Marleen HendriksDept of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. m.hendriks@amc-cpcd.org
Lizzy Brewster
Ferdinand Wit
Oladimeji Akeem Bolarinwa
Aina Olufemi Odusola
William Redekop
Navin Bindraban
Albert Vollaard
Shade Alli
Peju Adenusi
Kayode Agbede
Tanimola Akande
Joep Lange
Constance Schultsz
Academic Medical Center · NLPharmAccess Group · NLUniversity of Amsterdam · NLUniversity of Ilorin Teaching Hospital · NGAmsterdam Institute for Global Health and Development · NLErasmus MC · NLNigerian Institute of International Affairs · NGOxford University Clinical Research Unit · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiovascular diseases (CVD) are a leading contributor to the burden of disease in low- and middle-income countries. Guidelines for CVD prevention care in low resource settings have been developed but little information is available on strategies to implement this care. A community health insurance program might be used to improve patients' access to care. The operational research project "QUality Improvement Cardiovascular care Kwara - I (QUICK-I)" aims to assess the feasibility of CVD prevention care in rural Nigeria, according to international guidelines, in the context of a community based health insurance scheme. METHODS/

design

designprospective observational hospital based cohort study.

settinga primary health care centre in rural Nigeria. STUDY POPULATION: 300 patients at risk for development of CVD (patients with hypertension, diabetes, renal disease or established CVD) who are enrolled in the Hygeia Community Health Plan. MEASUREMENTS: demographic and socio- economic data, physical and laboratory examination, CVD risk profile including screening for target organ damage. MEASUREMENTS will be done at 3 month intervals during 1 year. Direct and indirect costs of CVD prevention care will be estimated. OUTCOMES: 1) The adjusted cardiovascular quality of care indicator scores based on the "United Kingdom National Health Services Quality and Outcome Framework". 2) The average costs of CVD prevention and treatment per patient per year for patients, the clinic and the insurance company. 3) The estimated net health care costs of standard CVD prevention care per quality-adjusted life year gained. ANALYSIS: The primary outcomes, the score on CVD quality indicators and cost data will be descriptive. The quality scores and cost data will be used to describe the feasibility of CVD prevention care according to international guidelines. A cost-effectiveness analysis will be done using a Markov model. DISCUSSION: Results of QUICK-I can be used by policy makers and professionals who aim to implement CVD prevention programs in settings with limited resources. The context of the insurance program will provide insight in the opportunities community health insurance may offer to attain sustainable chronic disease management programs in low resource settings.

trial registrationThis protocol has been registered at ISRCTN, ID number: ISRCTN47894401.

Indexed as

Community NetworksCardiovascular DiseasesCost-Benefit AnalysisFeasibility StudiesHumansInsurance, HealthNigeriaPrimary Health CareProgram EvaluationProspective StudiesQuality Indicators, Health CareRisk FactorsRural Health ServicesSocioeconomic Factors

Identifiers

PMID21439057
PMCPMC3073902
OpenAlexW2152146561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.